Showing results (581-590 of 9,400) with videos related to

Sort By:
Pageof 940
Clinical Pharmacology and Therapeutics|October 7, 2017
Global Regulatory Differences for Gene- and Cell-Based Therapies: Consequences and Implications for Patient Access and Therapeutic InnovationDelphi G M Coppens, Marie L De Bruin, Hubert G M Leufkens, et al.
Clinical Pharmacology and Therapeutics|October 10, 2017
Effect of Chronic Kidney Disease on Nonrenal Elimination Pathways: A Systematic Assessment of CYP1A2, CYP2C8, CYP2C9, CYP2C19, and OATPMing-Liang Tan, Kenta Yoshida, Ping Zhao, et al.
Clinical Pharmacology and Therapeutics|August 1, 1986
Pressor response of oral tyramine in healthy men given amiflamine and placeboM Grind, B Siwers, C Graffner, et al.
Clinical Pharmacology and Therapeutics|August 1, 1986
Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapyL A Bauer, M Stenwall, J R Horn, et al.
Clinical Pharmacology and Therapeutics|January 1, 1987
Physiologic and subjective changes from smokeless tobacco withdrawalD K Hatsukami, S W Gust, R M Keenan
Clinical Pharmacology and Therapeutics|January 1, 1987
Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humansC H Kleinbloesem, P van Brummelen, M Danhof, et al.
Clinical Pharmacology and Therapeutics|January 1, 1987
The effect of coadministration of verapamil on the pharmacokinetics and metabolism of quinidineD J Edwards, R Lavoie, H Beckman, et al.
Clinical Pharmacology and Therapeutics|January 1, 1987
The absence of significant biliary excretion of antipyrine or its metabolites in humansP S Wissel, A Kappas
Clinical Pharmacology and Therapeutics|March 1, 1987
Hydroxylation of desmethylimipramine: dependence on the debrisoquin hydroxylation phenotypeE Spina, E Steiner, O Ericsson, et al.
Pageof 940